Contribution of spinal cord oligodendrocytes to neuroinflammatory diseases and pain.
CONCLUSION: Findings from a number of clinical and experimental paradigms suggest spinal cord OPCs/oligodendrocytes are a potential therapeutic target for the control of neuroinflammation.
PMID: 29788868 [PubMed - as supplied by publisher]
Source: Current Medicinal Chemistry - Category: Chemistry Authors: Borghi SM, Fattori V, Hohmann MSN, Verri WA Tags: Curr Med Chem Source Type: research
More News: ALS | Autoimmune Disease | Back Pain | Brain | Chemistry | Chronic Pain | Gastroschisis Repair | Molecular Biology | Multiple Sclerosis | Neurology | Pain | Pain Management | Pathology | Physiology | Spinal Cord Injury